A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells (Q28578219)

31 January 2017

title

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells (English)

1 reference

31 January 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707342

4 November 2022

1 reference

Martin Hofmann-Apitius

2

object named as

M. Hofmann

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707342

4 November 2022

author name string

U. Günthert

1

1 reference

31 January 2017

W. Rudy

3

1 reference

31 January 2017

S. Reber

4

1 reference

31 January 2017

M. Zöller

5

1 reference

31 January 2017

I. Haussmann

6

1 reference

31 January 2017

S. Matzku

7

1 reference

31 January 2017

A. Wenzel

8

1 reference

31 January 2017

H. Ponta

9

1 reference

31 January 2017

P. Herrlich

10

1 reference

31 January 2017

language of work or name

English

0 references

publication date

5 April 1991

1 reference

full work available at URL

31 January 2017

https://api.elsevier.com/content/article/PII:009286749190403L?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

https://api.elsevier.com/content/article/PII:009286749190403L?httpAccept=text/plain

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

4 November 2022

1 reference

31 January 2017

volume

65

1 reference

31 January 2017

issue

1

1 reference

31 January 2017

page(s)

13–24

1 reference

CD44 is the principal cell surface receptor for hyaluronate

31 January 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Transcription termination and 3' processing: the end is in site!

4 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Prediction of protein conformation

4 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Invasive and metastatic potential induced by ras-transfection into mouse BW5147 T-lymphoma cells

4 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells

4 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation

4 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells

4 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer

4 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor

4 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides

4 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins

4 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

A one tube reaction for the synthesis of blunt-ended double-stranded cDNA

4 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

CD44--a molecule involved in leukocyte adherence and T-cell activation

4 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells

4 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium

4 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation

4 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Redistribution of a major cell surface glycoprotein during cell movement

4 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells

4 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells

4 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

4 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

4 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1.

4 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Natural cytotoxicity in lymphatic metastasis. II. In vivo studies with BSp73 variants differing in metastatic capacity.

4 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Metastasis inhibition of different tumor types by purified laminin fragments and a heparin-binding fragment of fibronectin

4 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade

4 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell

4 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Structural heterogeneity of human Pgp-1 and its relationship with p85.

4 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo

4 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types

4 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

The E1a gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells

4 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor

4 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies

4 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Improved plasmid vectors with a thermoinducible expression and temperature-regulated runaway replication

4 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

DNA sequencing with chain-terminating inhibitors

4 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

A cellular oncogene (c-Ki-ras) is amplified, overexpressed and located within karyotypic abnormalities in mouse adrenocortical tumour cells

4 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Polypeptide variation in an N-CAM extracellular immunoglobulin-like fold is developmentally regulated through alternative splicing

4 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Alternative splicing in the control of gene expression

4 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Expression of CD44 confers a new adhesive phenotype on transfected cells

4 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family

4 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

Evidence for a novel gene associated with low tumor metastatic potential

4 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

A new method for predicting signal sequence cleavage sites

4 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

cDNA cloning of a novel cell adhesion protein expressed in human squamous carcinoma cells

4 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90403-L

4 November 2022

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017